Nationwide Coverage and Cost-Sharing for PCSK9 Inhibitors Among Medicare Part D Plans

This study examines PCSK9i cost-sharing requirements for Medicare Part D plans nationwide, which insure 41 million beneficiaries.

Saved in:
Bibliographic Details
Published in:JAMA Cardiol
Main Authors: Kazi, Dhruv S., Lu, Christine Y., Lin, Grace A., DeJong, Colette, Dudley, R. Adams, Chen, Randi, Tseng, Chien-Wen
Format: Artigo
Language:Inglês
Published: American Medical Association 2017
Subjects:
Research Letter
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5815006/
https://ncbi.nlm.nih.gov/pubmed/28903137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamacardio.2017.3051
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items